Ιωάννη Κρανιδιώτη 2

555 35, Πυλαία, Θεσσαλονίκη

+30 2310 475 662

Καθημερινές : 9:00 - 14:00

info@hcds.gr

https://hcds.gr/epikoinonia/

HCDS -> RespiFit: development of a device for detecting tuberculosis mycobacterium

development of a device for detecting tuberculosis mycobacterium

The Hellenic Chest Diseases Society (H.C.D.S), supporting research in pulmonology, is proceeding to the initial funding of the company RespiFit LTD for the development of a prototype device for the detection of tuberculosis mycobacterium dispersed in air. About one quarter of the world population is thought to have latent infection with TB and more than one million people die each year.

RespiFit is a Digital Health SME providing personalized respiratory disease management and focusing on the intelligent monitoring of chronic respiratory diseases (e.g., asthma, COPD) as well as bio-safety against infectious disease agents.

 

We wish to RespiFit Good luck and the best results!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

στοιχεία σύνδεσης

Categories

Social Media Pages

Recent Posts

Archives

κοινοποιήστε στο :

Facebook
Twitter
LinkedIn
Pinterest
Skype
Email